BDR Pharma launches India's first generic Midostaurin for leukemia treatment
Midostaurin is launched under the brand name MSTARIN and will be available in the strength of 25 mg
Stay updated with breaking news from Bdr Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Midostaurin is launched under the brand name MSTARIN and will be available in the strength of 25 mg
Rucaparib is launched under the brand name BDPARIB in two strengths of 200 mg and 300 mg
BDR Pharma gets FDA nod to distribute Remdesivir to Maharashtra BDR Pharmaceutical International had produced Remdesivir vials for export purpose but with FDAâs order it has been permitted to distribute strictly for Maharashtra Government supply or trade in the state only Mumbai: In a bid to address the shortage of Remdesivir vials, the Food and Drugs Administration (FDA) in its order has allowed the BDR Pharmaceutical International to distribute Remdesivir injections under emergency and very high demanding situation for the state government supply and trade in Maharashtra only. The stat...